Atlas Trials

Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor

Clinical trial NCT02444390 · COMPLETED

Trial details

NCT number
NCT02444390
Sponsor
UNICANCER
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2015-05-19
Primary completion
2018-10-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.